The clinical characteristics of Malaysian patients with Takayasu Arteritis: A retrospective study of 3 decades

Autor: Ong, Ping S., Khor, Chiew G., Kan, Sow L., Lai, Ee L., Noh, Malehah M., Ch'ng, Shereen S., Isa, Liza B., Lim, Chong H., Ong, Swee G., Teh, Cheng L., Bin Othman, Ahmad Z., Maulana, Suhaida A., Shaharir, Shahrul S., Ling, Guo R., Abdul Rahim, Ruhaila, Jamid, Nurulraziquin M., Ab Rahim, Siti M., Liau, Swee M., Ismail, Asmahan M., Chong, Hwee C., Yahya, Fariz

Publikováno v: In The Egyptian Rheumatologist April 2024 46(2):67-72

Safety, efficacy and immunogenicity of aerosolized Ad5-nCoV COVID-19 vaccine in a non-inferiority randomized controlled trial.

Autor: Chew CK; Centre for Clinical Trial, Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia., Wang R; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Bavanandan S; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Zainudin N; Rheumatology Unit, Hospital Selayang, Selangor, Malaysia., Zhao X; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Ahmed S; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Nair D; Clinical Research Ward, Centre for Clinical Trial, Institute for Clinical Research, Hospital Ampang, Selangor, Malaysia., Hou L; Beijing Institute of Biotechnology, Beijing, China., Yahya R; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Ch'ng SS; Rheumatology Unit, Hospital Selayang, Selangor, Malaysia., Pang LH; Clinical Research Ward, Centre for Clinical Trial, Institute for Clinical Research, Hospital Ampang, Selangor, Malaysia., Abdul Aziz A; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Huang H; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Rajasuriar R; Immunotherapeutcis Laboratory and Department of Medicine, Faculty of Medicine, University Malaya, Kuala Lumpur, Malaysia., Wu S; Beijing Institute of Biotechnology, Beijing, China., Zhang Z; Beijing Institute of Biotechnology, Beijing, China., Wang X; Shanghai ImStat Medical Technology Co., Ltd., Shanghai, China., Chun GY; Centre for Clinical Trial, Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia., Mohd Norzi A; Clinical Research Ward, Centre for Clinical Trial, Institute for Clinical Research, Hospital Ampang, Selangor, Malaysia., Cheah KY; Clinical Research Ward, Centre for Clinical Trial, Institute for Clinical Research, Hospital Ampang, Selangor, Malaysia., Lee YL; Clinical Research Ward, Centre for Clinical Trial, Institute for Clinical Research, Hospital Ampang, Selangor, Malaysia., Wan Mohamad WH; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Mohd Din MR; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Wan Ahmad Kamil WMR; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Tan MH; Department of Nephrology, Hospital Kuala Lumpur, Kuala Lumpur, Malaysia., Xu X; Nanjing Vazyme Biotech Co., Ltd., Nanjing, China., Wang L; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Yan M; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Liu Y; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Chin VK; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Teo JS; Clindata Consult Sdn Bhd, Petaling Jaya, Selangor, Malaysia., Lim TO; Clin Research Private Enterprise, Petaling Jaya, Selangor, Malaysia., Zhu T; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China., Gou J; Clinical Operations Center, CanSino Biologics Inc., Tianjin, China. jinbo.gou@cansinotech.com., Ng SSM; Centre for Clinical Trial, Institute for Clinical Research, National Institutes of Health, Ministry of Health Malaysia, Selangor, Malaysia. sharonng@moh.gov.my.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2024 Oct 31; Vol. 9 (1), pp. 209. Date of Electronic Publication: 2024 Oct 31.